Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Impaired Respiratory Burst Contributes to Infections in Pkcδ-Deficient Patients Publisher Pubmed



Neehus AL1, 2, 3 ; Moriya K1, 2 ; Nietopatlan A1, 2, 4, 5 ; Voyer TL1, 2 ; Levy R1, 2, 6 ; Ozen A7 ; Karakocaydiner E7 ; Baris S7 ; Yildiran A8 ; Altundag E9 ; Roynard M1, 2 ; Haake K3 ; Migaud M1, 2 ; Dorgham K10 Show All Authors
Authors
  1. Neehus AL1, 2, 3
  2. Moriya K1, 2
  3. Nietopatlan A1, 2, 4, 5
  4. Voyer TL1, 2
  5. Levy R1, 2, 6
  6. Ozen A7
  7. Karakocaydiner E7
  8. Baris S7
  9. Yildiran A8
  10. Altundag E9
  11. Roynard M1, 2
  12. Haake K3
  13. Migaud M1, 2
  14. Dorgham K10
  15. Gorochov G10
  16. Abel L1, 2, 11
  17. Lachmann N3
  18. Dogu F12
  19. Haskologlu S12
  20. Ince E13
  21. Elbenna J14, 15
  22. Uzel G16
  23. Kiykim A17, 18
  24. Boztug K19, 20, 21, 22
  25. Roderick MR23
  26. Shahrooei M24, 25
  27. Brogan PA26
  28. Abolhassani H27, 28
  29. Hancioglu G8
  30. Parvaneh N29
  31. Belot A30
  32. Ikinciogullari A12
  33. Casanova JL1, 2, 11, 31
  34. Puel A1, 2, 11
  35. Bustamante J1, 2, 11, 32
Show Affiliations
Authors Affiliations
  1. 1. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Sante et de la Recherche Medicale UMR 1163, Paris, France
  2. 2. University of Paris, Imagine Institute, Paris, France
  3. 3. Institute of Experimental Hematology, REBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, Germany
  4. 4. Research and Development in Bioprocess Unit, National School of Biological Sciences, National Polytechnic Institute, Mexico City, Mexico
  5. 5. National Laboratory for Specialized Services of Investigation, Development and Innovation for Pharma Chemicals and Biotechnological Products, LANSEIDI-FarBiotec- CONACyT, Mexico City, Mexico
  6. 6. Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, Paris, France
  7. 7. Department of Pediatrics, Division of Allergy and Immunology, Marmara University, School of Medicine, Istanbul, Turkey
  8. 8. Department of Pediatric Immunology and Allergy, Ondokuz Mayis University, School of Medicine, Samsun, Turkey
  9. 9. Department of Medical Genetics, Ondokuz Mayis University, Faculty of Medicine, Samsun, Turkey
  10. 10. Sorbonne University, Institut National de la Sante et de la Recherche Medicale, Center for Immunology and Microbial Infections, CIMI-Paris, Assistance Publique-Hopitaux de Paris, Pitie-Salpetriere Hospital, Department of Immunology, Paris, France
  11. 11. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, United States
  12. 12. Department of Pediatric Immunology and Allergy, Ankara University, School of Medicine, Ankara, Turkey
  13. 13. Department of Pediatric Infectious Disease, Ankara University, School of Medicine, Ankara, Turkey
  14. 14. University of Paris, Institut National de la Sante et de la Recherche Medical U1149, Centre National de la Recherche Scientifique- ERL8252, Paris, France
  15. 15. Center for Research on Inflammation, Laboratory of Excellence Inflamex, Faculty of Medicine, Paris, Xavier Bichat, France
  16. 16. Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
  17. 17. Pediatric Allergy and Immunology, Marmara University Pediatric Training and Research Hospital, Istanbul, Turkey
  18. 18. Division of Pediatric Allergy and Immunology, Cerrahpasa School of Medicine, Istanbul University- Cerrahpasa, Istanbul, Turkey
  19. 19. CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria
  20. 20. St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
  21. 21. Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria
  22. 22. St. Anna Children's Cancer Research Institute, Vienna, Austria
  23. 23. Pediatric Immunology and Infectious Disease, Bristol Royal Hospital for Children, Bristol, United Kingdom
  24. 24. Specialized Immunology Laboratory of Dr. Shahrooei, Sina Medical Complex, Ahvaz, Iran
  25. 25. Department of Microbiology and Immunology, Clinical and Diagnostic Immunology, Katholieke Universiteit Leuven, Leuven, Belgium
  26. 26. Infection Inflammation and Rheumatology Section, Infection Immunity Inflammation and Physiological Medicine Programme, University College London Institute of Child Health, London, United Kingdom
  27. 27. Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden
  28. 28. Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran
  29. 29. Department of Pediatrics, Division of Allergy and Clinical Immunology, Tehran University ofMedical Sciences, Tehran, Iran
  30. 30. Reference Center for Rare Rheumatic and Autoimmune Diseases in Children, Pediatric Rheumatology, Hospices Civils de Lyon, Centre International de Recherche en Infectiologie, Institut National de la Sante et de la Recherche Medicale U1111, UMS3444/US8 Lyon University, Lyon, France
  31. 31. Howard Hughes Medical Institute, New York, NY, United States
  32. 32. Center for the Study of Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hopitaux de Paris, Paris, France

Source: Journal of Experimental Medicine Published:2021


Abstract

Patients with autosomal recessive protein kinase C δ (PKCδ) deficiency suffer from childhood-onset autoimmunity, including systemic lupus erythematosus. They also suffer from recurrent infections that overlap with those seen in patients with chronic granulomatous disease (CGD), a disease caused by defects of the phagocyte NADPH oxidase and a lack of reactive oxygen species (ROS) production. We studied an international cohort of 17 PKCδ-deficient patients and found that their EBV-B cells and monocyte-derived phagocytes produced only small amounts of ROS and did not phosphorylate p40phox normally after PMA or opsonized Staphylococcus aureus stimulation. Moreover, the patients' circulating phagocytes displayed abnormally low levels of ROS production and markedly reduced neutrophil extracellular trap formation, altogether suggesting a role for PKCδ in activation of the NADPH oxidase complex. Our findings thus show that patients with PKCδ deficiency have impaired NADPH oxidase activity in various myeloid subsets, which may contribute to their CGD-like infectious phenotype. © 2021 Neehus et al.